Kavalan Unveils 2026 Lunar New Year Exclusive: Golden Steed & Peonies and Miniature Whisky Gift Set

by | PRNewswire Asia

A tribute to the Year of the Horse with symbolic artistry and signature single malt complexity TAIPEI, Jan. 15, 2026 /PRNewswire/ — Kavalan, Taiwan’s internationally acclaimed whisky distillery, introduces its 2026 Lunar New Year exclusive: Golden Steed...

Yuyu Pharma Establishes UCLA Office to Accelerate U.S. Pet Industry Expansion

by | PRNewswire Asia

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ — Yuyu Bio and Mervyn’s Petcare, pet-focused subsidiaries of Yuyu Pharma, have opened a new office on the UCLA campus, strengthening the company’s presence in the United States pet and animal health...

Kerry Releases 2026 Global Taste Charts, Delivering Data‑Rich Insights to Power the Future of Flavour

by | PRNewswire Asia

SINGAPORE, Jan. 14, 2026 /PRNewswire/ — Kerry, a global leader in taste and nutrition, today unveiled its 2026 Global Taste Charts, providing the food and beverage industry with its most comprehensive and forward‑looking view of flavour evolution. Built on...

2026 Taiwan Foxconn Ladies Golf Tournament Returns With New Branding, Record US$2 Million Purse, Japan Tour

by | PRNewswire Asia

TAIPEI, Jan. 14, 2026 /PRNewswire/ — The LPGA of Taiwan (TLPGA) and the Japan Ladies Professional Golfers’ Association are thrilled to announce the "2026 Taiwan Foxconn Ladies Golf Tournament" on the official circuit of JLPGA for this year,...

OMOWAY Raises Eight-Figure USD to Scale the World's First Mass-Produced Self-Balancing E-Motorcycle

by | PRNewswire Asia

SINGAPORE, Jan. 14, 2026 /PRNewswire/ — OMOWAY, a pioneer in two-wheeled smart mobility, has successfully closed consecutive Pre-A and Pre-A+ funding rounds, raising tens of millions of US dollars. The investment was led by HONGSHAN and ROCKET CAPITAL, with...

Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

by | PRNewswire Asia

HONG KONG, Jan. 14, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus chemotherapy...